Pronóstico del mercado de equipos y reactivos de transfección de América del Sur y Central hasta 2030 – Análisis regional – por producto (reactivos e instrumentos), método (métodos virales, métodos no virales y métodos híbridos), aplicación (investigación biomédica, producción de proteínas y administración terapéutica) y usuario final (académicos e institutos de investigación y empresas farmacéuticas y de biotecnología)
La creciente carga económica del cáncer impulsa el mercado de equipos y reactivos de transfección en América del Sur y Central
Según la Organización Mundial de la Salud ( OMS), el cáncer es una de las principales causas de muerte en todo el mundo y representó ~10 millones de muertes en 2020. Según la Agencia Internacional para la Investigación del Cáncer, es probable que la carga mundial del cáncer aumente con la adición de 30,2 millones más. casos para 2040. Según la Organización del Cáncer de Mama, aproximadamente entre el 5% y el 10% de los casos de cáncer de mama en todo el mundo son hereditarios y están causados por genes anormales transmitidos de generación en generación. Según el artículo \"Estilo de vida, riesgo genético e incidencia del cáncer\", publicado en la Revista Internacional de Epidemiología en 2023, casi el 33% de los cánceres que ocurren son hereditarios y el riesgo de mutaciones genéticas es alto en la enfermedad. De ahí que las personas estén optando por el perfil genético para la detección precoz y el tratamiento personalizado de los casos de cáncer hereditario. A BRCA1 y BRCA2 a veces se les denomina genes supresores de tumores. Las personas que heredan las variantes dañinas de uno de estos genes tienen un mayor riesgo de sufrir varios cánceres, sobre todo cáncer de mama y de ovario, entre otros tipos. Estas personas también tienden a desarrollar cáncer a edades más tempranas en comparación con las personas que no tienen variaciones en dichos genes. Es probable que los estudios centrados en el procesamiento de ácidos nucleicos por parte de las células cancerosas ayuden a comprender el metabolismo del cáncer. El ADN normalmente se empaqueta en una partícula viral o no viral para transferirla a la célula que se va a transfectar. La transferencia de genes se ha propuesto como un nuevo enfoque para mejorar la eficacia de los fármacos antitumorales en el tratamiento de cánceres intratables o metastásicos. Se ha informado que la asociación de terapia génica y fármacos (terapia similar) fortalece los efectos antiproliferativos de los tratamientos clásicos en el cáncer de pulmón, colorrectal, páncreas, vejiga y mama, entre otros. Por lo tanto, la creciente carga económica del cáncer refuerza el mercado de equipos y reactivos de transfección de América del Sur y Central.
Reactivos y equipos de transfección de América del Sur y Central Descripción general del mercado
La región de América del Sur y Central está segmentada en Brasil, Argentina y el resto de América del Sur y Central. Brasil tendrá más de la mitad de la participación regional en el año 2022.
Brasil ha logrado avances significativos en la industria farmacéutica debido a sus políticas y reformas económicas favorables, un sólido control de la producción farmacéutica nacional y un elevado gasto en atención médica. . Según la Administración de Comercio Internacional (ITA), Brasil es el mercado sanitario más grande de América Latina y gasta el 9,1% de su PIB en atención sanitaria. Las empresas nacionales dominan la producción total de productos farmacéuticos del país, lo que permite sus actividades comerciales. Según el Departamento de Comercio de EE. UU., las empresas nacionales representan aproximadamente el 80% del total de empresas farmacéuticas en Brasil. Por lo tanto, el creciente panorama de la industria farmacéutica es uno de los principales factores para el crecimiento del mercado de equipos y reactivos de transfección en Brasil.
Además, Argentina tiene la industria farmacéutica más grande de América del Sur y Central, después de Brasil. El crecimiento del mercado de equipos y reactivos de transfección en el país está impulsado en gran medida por amplios esfuerzos de investigación y desarrollo y la creciente producción nacional de productos farmacéuticos. Es probable que la creciente demanda de productos farmacéuticos y biofarmacéuticos debido a las crecientes incertidumbres de las condiciones de salud, el entorno regulatorio cada vez más poderoso para la industria farmacéutica y la mejora de la logística de las materias primas favorezcan el crecimiento del mercado de reactivos y equipos de transfección en Argentina durante el período de pronóstico. .
Ingresos y pronóstico del mercado de equipos y reactivos de transfección de América del Sur y Central hasta 2030 (millones de dólares estadounidenses)
Segmentación del mercado de equipos y reactivos de transfección de América del Sur y Central
El mercado de equipos y reactivos de transfección de América Central está segmentado según el producto, el método, la aplicación, el usuario final y el país.
Según el producto, el mercado de equipos y reactivos de transfección de América del Sur y Central se divide en reactivos e instrumentos. El segmento de reactivos tuvo una participación mayor en 2022.
En términos de método, el mercado de equipos y reactivos de transfección de América del Sur y Central se segmenta en métodos virales, métodos no virales y métodos híbridos. El segmento de métodos no virales tuvo la mayor participación en 2022. El segmento viral se subcategoriza en retrovirus, adenovirus, virus adenoasociados y virus del herpes. El segmento no viral se bifurca en método físico/mecánico y método químico. Además, el segmento de métodos físicos/mecánicos se subclasifica en electroporación, microinyección, método biolístico, método láser, magnetofección y sonoporación. Además, el segmento del método químico se subcategoriza en basado en liposomas/alto en lípidos y no liposomal/alto en lípidos.
Por aplicación, el mercado de equipos y reactivos de transfección de América del Sur y Central está segmentado en investigación biomédica, producción de proteínas y administración terapéutica. El segmento de investigación biomédica tuvo la mayor participación en 2022.
Según el usuario final, el mercado de equipos y reactivos de transfección de América del Sur y Central se divide en académicos e institutos de investigación y empresas farmacéuticas y de biotecnología. El segmento de institutos académicos e institutos de investigación tuvo una participación mayor en 2022.
Según el país, el mercado de equipos y reactivos de transfección de América del Sur y Central se clasifica en Brasil, Argentina y el resto de América del Sur y Central. Brasil dominó el mercado de equipos y reactivos de transfección de América del Sur y Central en 2022.
Thermo Fisher Scientific Inc, Promega Corp, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Mirus Bio LLC, QIAGEN NV, Merck KGaA, Lonza Group AG y MaxCyte Inc son algunas de las empresas líderes que operan en el mercado de equipos y reactivos de transfección de América del Sur y Central.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Transfection Reagents and Equipment Market - Key Market Dynamics
4.1 South & Central America Transfection Reagents and Equipment Market - Key Market Dynamics
4.2 Market Drivers
4.2.1 Increasing Popularity of Cell and Gene Therapy
4.2.2 Growing Economic Burden of Cancer
4.3 Market Restraints
4.3.1 High Cost of Instruments and Consumables
4.4 Market Opportunities
4.4.1 Ramping Up Small-Scale Processes to Large-Scale Processes
4.5 Future Trends
4.5.1 Strategic Initiatives by Companies
4.6 Impact of Drivers and Restraints:
5. Transfection Reagents and Equipment Market - South & Central America Market Analysis
5.1 South & Central America Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
5.2 South & Central America Transfection Reagents and Equipment Market Forecast Analysis
6. South & Central America Transfection Reagents and Equipment Market Analysis - by Product
6.1 Reagents
6.1.1 Overview
6.1.2 Reagents: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
6.2 Equipment
6.2.1 Overview
6.2.2 Equipment: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7. South & Central America Transfection Reagents and Equipment Market Analysis - by Modality
7.1 Viral
7.1.1 Overview
7.1.2 Viral: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.1 Retrovirus: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.2 Adenovirus: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.3 Adeno-Associated Virus: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.4 Herpes Virus: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Non-Viral
7.2.1 Overview
7.2.2 Non-Viral: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1 Physical/Mechanical Method: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.1 Electroporation: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.2 Microinjection: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.3 Biolistic Method: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.4 Laser Method: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.5 Magnetofection: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.6 Sonoporation: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2 Chemical Method: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2.1 Liposomal Based/High Lipid: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2.2 Non-Liposomal Based/High Lipid: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Hybrid
7.3.1 Overview
7.3.2 Hybrid: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Transfection Reagents and Equipment Market Analysis - by Application
8.1 Biomedical Research
8.1.1 Overview
8.1.2 Biomedical Research: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Protein Production
8.2.1 Overview
8.2.2 Protein Production: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Therapeutic Delivery
8.3.1 Overview
8.3.2 Therapeutic Delivery: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Transfection Reagents and Equipment Market Analysis - by End Users
9.1 Academic and Research Institutes
9.1.1 Overview
9.1.2 Academic and Research Institutes: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Pharmaceutical and Biotechnological Companies
9.2.1 Overview
9.2.2 Pharmaceutical and Biotechnological Companies: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Transfection Reagents and Equipment Market -Country Analysis
10.1.1 South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
10.1.1.1 South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
10.1.1.2 Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Brazil: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.2.2 Brazil: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.2.2.1 Brazil: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.2.2.2 Brazil: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.2.2.2.1 Brazil: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.2.2.2.2 Brazil: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.2.3 Brazil: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.2.4 Brazil: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.1.3 Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Argentina: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.3.2 Argentina: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.3.2.1 Argentina: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.3.2.2 Argentina: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.3.2.2.1 Argentina: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.3.2.2.2 Argentina: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.3.3 Argentina: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.3.4 Argentina: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.1.4 Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.4.2 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.4.2.1 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.4.2.2 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.4.2.2.1 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.4.2.2.2 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.4.3 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.4.4 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by End Users
11. Transfection Reagents and Equipment Market -Industry Landscape
11.1 Overview
11.2 Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Thermo Fisher Scientific Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Promega Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 F. Hoffmann-La Roche Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Bio-Rad Laboratories Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Mirus Bio LLC
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 QIAGEN NV
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Merck KGaA
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Lonza Group AG
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 MaxCyte Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About Us
List of Tables
Table 1. South & Central America Transfection Reagents and Equipment Market Segmentation
Table 2. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 4. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Modality
Table 5. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Viral
Table 6. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Non-Viral
Table 7. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Physical/mechanical Method
Table 8. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Chemical Method
Table 9. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 10. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by End Users
Table 11. South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Country
Table 12. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 13. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 14. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 15. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 16. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 17. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 18. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 19. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 20. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 21. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 22. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 23. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 24. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 25. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 26. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 27. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 28. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 29. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 30. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 31. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 32. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 33. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 34. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 35. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 36. Recent Inorganic Growth Strategies in the Transfection Reagents and Equipment Market
Table 37. Recent Organic Growth Strategies in The Transfection Reagents and Equipment Market
List of Figures
Figure 1. South & Central America Transfection Reagents and Equipment Market Segmentation, by Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. South & Central America Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
Figure 4. South & Central America Transfection Reagents and Equipment Market Share (%) - by Product (2022 and 2030)
Figure 5. Reagents: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 6. Equipment: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. South & Central America Transfection Reagents and Equipment Market Share (%) - by Modality (2022 and 2030)
Figure 8. Viral: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Retrovirus: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Adenovirus: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Adeno-Associated Virus: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Herpes Virus: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Non-Viral: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Physical/Mechanical: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Electroporation: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Microinjection: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Biolistic Method: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Laser Method: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Magnetofection: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Sonoporation: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Chemical Method: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Liposomal Based/High Lipid: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Non-Liposomal Based/High Lipid: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Hybrid: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. South & Central America Transfection Reagents and Equipment Market Share (%) - by Application (2022 and 2030)
Figure 26. Biomedical Research: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Protein Production: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Therapeutic Delivery: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. South & Central America Transfection Reagents and Equipment Market Share (%) - by End Users (2022 and 2030)
Figure 30. Academic and Research Institutes: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Pharmaceutical and Biotechnological Companies: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. South & Central America: Transfection Reagents and Equipment Market- Revenue by Key Countries 2022 (US$ Million)
Figure 33. South & Central America: Transfection Reagents and Equipment Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 34. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 35. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 36. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 37. Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023
1. Thermo Fisher Scientific Inc
2. Promega Corp
3. F. Hoffmann-La Roche Ltd
4. Bio-Rad Laboratories Inc
5. Mirus Bio LLC
6. QIAGEN NV
7. Merck KGaA
8. Lonza Group AG
9. MaxCyte Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America transfection reagents and equipment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in South & Central America transfection reagents and equipment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.